Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02560129
Other study ID # IRB00031295
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2015
Est. completion date November 30, 2023

Study information

Verified date June 2024
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Summary: Emerging data demonstrate long-term morbidity and mortality in those who survive critical illness. However, there is no data regarding long-term follow-up for ICU survivors. The investigators have begun the implementation of an ICU recovery clinic. Rationale: ICU survivors are at high risk for functional, cognitive and psychiatric impairments. However, methods to mitigate these impairments and improve recovery are lacking. Special follow-up clinics for survivors of critical illness have been proposed and implemented to some degree, but are uncommon.


Description:

Objectives: 1. To evaluate physical function, cognitive function, and overall functional status during recovery from critical illness. 2. To evaluate anxiety, depression, and PTSD during recovery from critical illness. 3. To evaluate resilience during recovery from critical illness. 4. To evaluate healthcare utilization rates, morbidity, and mortality following critical illness. 5. Added April 2016: To study the voice and swallowing function of patients following recovery from critical illness. 6. Added April 2016: To study the pain of patients following recovery from critical illness. Intervention: A prospective observational study of all patients who attend our ICU recovery clinic. Methods: Patients will be identified for participation in our ICU Recovery Clinic during their admission to the Wake Forest Baptist Medical Center Medical Intensive Care Unit (MICU). They will be asked to return to the ICU recovery clinic within 1 month of hospital discharge. Structured clinic visits as standard of care will include medication reconciliation and evaluation by a pharmacist, along with an evaluation by a clinic physician to address acute medical issues and provide counselling. They will also undergo standardized testing to evaluate physical function, cognitive function, and psychiatric function. Added April 2016: They will also undergo a standardized evaluation of speech, swallow, and pain.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date November 30, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: Wake Forest MICU Admission - sepsis OR - respiratory failure requiring >24 hrs of invasive mechanical ventilation - previously functional Exclusion Criteria: - Active Malignancy

Study Design


Intervention

Other:
Questionnaires, Physical and Cognitive Function
ICU survivors will be administered a battery of questionnaires. Measurements of physical and cognitive function will also be performed.

Locations

Country Name City State
United States Wake Forest Baptist Medical Center Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Swallow Function EAT 10 Questionnaire 6 months
Other Speech Voice Analysis 6 months
Other Pain Brief Pain Inventory, modified version of the modified musculoskeletal questionnaire 6 months
Primary Physical Function as measured by the Short Performance Physical Battery 6 months
Secondary Physical Function Handgrip strength 6 months
Secondary Cognitive Function Montreal Cognitive Assessment 6 months
Secondary Anxiety/ Depression Screening Hospital Anxiety and Depression Scale 6 months
Secondary Post Traumatic Stress Disorder Screening Impact of Events Scale- Revised 6 months
Secondary Functional Status Activities of Daily Living and Instrumental Activities of Daily Living 6 months
Secondary Resilience Connor-Davidson Resilience Scale- 10 6 months
Secondary Quality of Life Short-Form 36 6 months
Secondary Hospital Readmissions 6 months
Secondary Mortality 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3